Chemomab Therapeutics Ltd. Operating Lease Right-of-Use Assets
Chemomab Therapeutics Ltd. (CMMB) had Operating Lease Right-of-Use Assets of $0 as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-03-23
- 2025-12-31: Operating Lease, Right-of-Use Asset $0.00.
- 2025-06-30: Operating Lease, Right-of-Use Asset $0.00.
- 2024-12-31: Operating Lease, Right-of-Use Asset $289.00K.
- 2024-06-30: Operating Lease, Right-of-Use Asset $341.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2025-12-31 | $0.00 20-F · filed 2026-03-23 | |
| 2025-06-30 | $0.00 6-K · filed 2025-08-14 | |
| 2024-12-31 | $289.00K 20-F · filed 2026-03-23 | |
| 2024-06-30 | $341.00K 6-K · filed 2024-08-21 | |
| 2023-12-31 | $392.00K 20-F · filed 2026-03-23 | |
| 2023-06-30 | $160.00K 6-K · filed 2023-08-14 | |
| 2023-03-31 | $193.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $227.00K 20-F · filed 2024-03-28 | |
| 2022-09-30 | $261.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $295.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $309.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $345.00K 20-F · filed 2024-03-28 | |
| 2021-09-30 | $359.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $392.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $397.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $428.00K 10-K · filed 2022-03-30 | $0.00 10-K · filed 2021-03-09 |
| 2020-09-30 | $234.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $275.00K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $339.00K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $1.20M 10-K · filed 2021-03-09 | |
| 2019-01-01 | $1.81M 10-K · filed 2020-03-17 |